DTC genetic testing is a service that is offered by companies, retail, and clinical diagnostic laboratories directly to the consumer. DTC genetic testing services are marketed to consumers through television and print and online advertisements. DTC genetic testing is widely adopted owing to increasing awareness about gene sequencing for the early detection of diseases. However, in many countries, companies also conduct gene sequencing for matchmaking, to ascertain ancestry, and to check the vitamin level in the body.

Scope of the Report:
This report studies the Direct-to-consumer Genetic Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Direct-to-consumer Genetic Testing market by product type and applications/end industries.
The prevalence of chronic diseases among the adult and older population such as cardiovascular diseases (CVDs), type 2 diabetes, diabetic retinopathy, and age-related macular degeneration is contributing to the increasing customer awareness about directto consumer (DTC) genetic testing. The rising prevalence of chronic diseases has resulted in increased healthcare expenditure and the DTC genetic testing aids in early diagnosis.
The DTC genetic testing market is highly fragmented due to the presence of several Tier 1, Tier 2, and Tier 3 companies who compete based on factors such as aggressive pricing, product differentiation, capital support for product upgrades, and distribution partnerships. The competition among the manufacturers will intensify due to the advances in technology and product upgrades.
The DTC genetic testing market contains two business models; one-to-one and one-to-many. In the one-to-one model, the results are discussed directly by the companies with the consumer or with the physician. In the one-to-many model, DTC companies will only conduct a genetic test once they receive consent from the consumer and the data is owned by the companies. DTC genetic testing companies obtains profit from the sales of DTC genetic testing kits to the consumer, physician, and the sales of genetic data to pharmaceutical companies. The paradigm shift in business models is identified as one of the key trends behind the growth of the DTC genetic testing market.
The global Direct-to-consumer Genetic Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Direct-to-consumer Genetic Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Get a FREE sample Copy of this report : https://www.1marketresearch.com/market-reports/direct-to-consumer-genetic-testing-market-industry-report-87091#requestSample

Market Segment by Manufacturers, this report covers

23andMe
LabCorp
Myriad Genetics
Quest Diagnostics
African Ancestry
Alpha Biolaboratories
Ambry Genetics
AncestrybyDNA
Anglia DNA Services
Canadian DNA Services
Centrillion Technology
Color Genomics
Counsyl
Dante Labs
DNA Diagnostics Center
DNA Family Check
DNA4Life
DNA Services of America
EasyDNA
Full Genomes
24genetics
Gene By Gene
GHC GENETICS
Genetic Health
IDENTIGENE
IntelliGenetics
Invitae
Living DNA
Walk-In Lab
Xcode
Mapmygenome
MyHeritage
Pathway Genomics
Positive Bioscience
SureGenomics
Shuwen Health Sciences
Sonora Quest Laboratories
Test Me DNA
VCGS

Browse Report :https://www.1marketresearch.com/market-reports/direct-to-consumer-genetic-testing-market-industry-report-87091

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Diagnostic Screening
Prenatal, newborn screening, pre-implantation diagnosis
Relationship testing

Market Segment by Applications, can be divided into
Direct sales
Retail sales
Laboratory sales



Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *